Based on the positive results, our novel bioconjugates were tested in vitro on Detroit-562 human pharyngeal carcinoma cells that have already been demonstrated to express GnRH receptors in high levels [40]. This evidence concerns the gene GNRHR and carcinoma of pharynx.